In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

Haemonetics enters $700mm loan agreement

20 Jun 2018

Executive Summary

Haemonetics Corp. (blood management devices and services) entered into a $700mm loan agreement, which includes a $350mm unsecured term loan and a $350mm senior unsecured revolving credit facility. Both loans bear interest at an annual rate of LIBOR plus 1.25% and are due in 2023. Proceeds will be used to repay an existing $254mm senior unsecured term loan due June 2019.
Deal Industry
  • Medical Devices
  • Services
  • Medical Devices
    • Diagnostic Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Financing
    • Nonconvertible Debt
    • Private Placement

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By